About Flash Therapeutics
Flash Therapeutics is a company based in Toulouse (France) founded in 2005.. Flash Therapeutics has raised $11.54 million across 6 funding rounds from investors including TechLife Capital, Elaia and Galia Gestion. Flash Therapeutics operates in a competitive market with competitors including Moderna, Horizon Therapeutics, Forge Biologics, Avidity Biosciences and argenx, among others.
- Headquarter Toulouse, France
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$11.54 M (USD)
in 6 rounds
-
Latest Funding Round
$4.72 M (USD), Series A
Jul 01, 2021
-
Investors
TechLife Capital
& 9 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Flash Therapeutics
Flash Therapeutics has successfully raised a total of $11.54M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $4.72 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series A — $4.7M
-
First Round
First Round
(26 May 2010)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Series A - Flash Therapeutics | Valuation |
investors |
|
| May, 2018 | Amount | Series A - Flash Therapeutics | Valuation |
investors |
|
| Aug, 2017 | Amount | Grant - Flash Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Flash Therapeutics
Flash Therapeutics has secured backing from 10 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include TechLife Capital, Elaia and Galia Gestion. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on early-stage investments
|
Founded Year | Domain | Location | |
|
Galia Gestion is engaged in private equity investments in southwestern France.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Flash Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Flash Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Flash Therapeutics Comparisons
Competitors of Flash Therapeutics
Flash Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Horizon Therapeutics, Forge Biologics, Avidity Biosciences and argenx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for treating rare and autoimmune diseases
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases are developed to treat patients.
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment.
|
|
| domain | founded_year | HQ Location |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Flash Therapeutics
Frequently Asked Questions about Flash Therapeutics
When was Flash Therapeutics founded?
Flash Therapeutics was founded in 2005 and raised its 1st funding round 5 years after it was founded.
Where is Flash Therapeutics located?
Flash Therapeutics is headquartered in Toulouse, France. It is registered at Toulouse, Occitanie, France.
Is Flash Therapeutics a funded company?
Flash Therapeutics is a funded company, having raised a total of $11.54M across 6 funding rounds to date. The company's 1st funding round was a Grant of $59.66K, raised on May 26, 2010.
What does Flash Therapeutics do?
The company was founded in 2005 and is based in Toulouse, France. Operations focus on the biotechnology sector, where gene and cell-based therapies are developed for conditions such as IPEX syndrome and lymphedema. Technologies employed include a lentiviral platform, transient RNA delivery, CAR-T cancer immunotherapy, and gene-editing tools. These efforts target therapeutic solutions for various disorders.
Who are the top competitors of Flash Therapeutics?
Flash Therapeutics's top competitors include Moderna, argenx and Forge Biologics.
Who are Flash Therapeutics's investors?
Flash Therapeutics has 10 investors. Key investors include TechLife Capital, Elaia, Galia Gestion, Jean-Pierre Arnaud, and Alain Sainsot.